Literature DB >> 8289362

Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain.

C P Spies1, G D Ritter, M J Mulligan, R W Compans.   

Abstract

We previously reported that truncation of the cytoplasmic domain of the macaque simian immunodeficiency virus SIVmac239 envelope glycoprotein enhanced its ability to induce cell fusion in a variety of cell lines. In the present study, we examined the expression of the full-length and truncated SIVmac239 envelope glycoprotein complex on cell surfaces. Using a membrane-impermeable reagent to biotinylate proteins on cell surfaces followed by immunoprecipitation, we found that under conditions in which the full-length TM protein could not be detected on the surfaces of CD4-positive or CD4-negative cell lines, the truncated TM protein was detected efficiently. In contrast, using a membrane-impermeable iodination reagent to label proteins on cell surfaces, we could detect both the full-length and truncated TM proteins. No difference between the full-length and truncated proteins was observed in the detection of the SU proteins in the biotinylation assay. Additionally, we used an assay in which SIV-specific antibodies are prebound to the native envelope proteins expressed on the cell surface and then the proteins are immunoprecipitated. Using this assay, we could not detect the truncated or full-length TM protein on the cell surface, whereas we could detect the SU subunits of both proteins. We also observed that the truncated TM protein formed more stable sodium dodecyl sulfate-resistant oligomers than the full-length TM protein did. These results indicate that truncation of the cytoplasmic domain of the SIVmac239 envelope glycoprotein affects the conformation of the external domain of the TM protein on the cell surface, even though the two proteins have no differences in the amino acid sequences of their external domains. This altered conformation could play a role in the enhanced fusion activity of the truncated SIV glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289362      PMCID: PMC236490          DOI: 10.1128/JVI.68.2.585-591.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.

Authors:  R J Owens; R W Compans
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

2.  Shorter size of transmembrane glycoprotein of an HIV-1 isolate.

Authors:  H Shimizu; S Morikawa; K Yamaguchi; H Tsuchie; K Hachimori; H Ushijima; T Kitamura
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

Review 3.  Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac).

Authors:  P A Luciw; K E Shaw; R E Unger; V Planelles; M W Stout; J E Lackner; E Pratt-Lowe; N J Leung; B Banapour; M L Marthas
Journal:  AIDS Res Hum Retroviruses       Date:  1992-03       Impact factor: 2.205

4.  Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Authors:  P L Earl; S Koenig; B Moss
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

5.  The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes.

Authors:  O K Haffar; D J Dowbenko; P W Berman
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

6.  Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein.

Authors:  R M Venable; R W Pastor; B R Brooks; F W Carson
Journal:  AIDS Res Hum Retroviruses       Date:  1989-02       Impact factor: 2.205

7.  Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  D H Gabuzda; A Lever; E Terwilliger; J Sodroski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide.

Authors:  N Green; T M Shinnick; O Witte; A Ponticelli; J G Sutcliffe; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein.

Authors:  S K Srinivas; R V Srinivas; G M Anantharamaiah; J P Segrest; R W Compans
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

10.  Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein.

Authors:  E Helseth; U Olshevsky; C Furman; J Sodroski
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more
  69 in total

1.  Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.

Authors:  I Rousso; M B Mixon; B K Chen; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.

Authors:  John T West; Sally K Weldon; Stephanie Wyss; Xiaoxu Lin; Qin Yu; Markus Thali; Eric Hunter
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.

Authors:  J P Moore; P W Parren; D R Burton
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.

Authors:  A Bültmann; W Muranyi; B Seed; J Haas
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation.

Authors:  G B Melikyan; R M Markosyan; S A Brener; Y Rozenberg; F S Cohen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity.

Authors:  C Yang; R W Compans
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling.

Authors:  Hector C Aguilar; Kenneth A Matreyek; Daniel Y Choi; Claire Marie Filone; Sophia Young; Benhur Lee
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

8.  A polarized human endometrial cell line that binds and transports polymeric IgA.

Authors:  J M Ball; Z Moldoveanu; L R Melsen; P A Kozlowski; S Jackson; M J Mulligan; J F Mestecky; R W Compans
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

9.  Functional domains in the retroviral transmembrane protein.

Authors:  Y Zhao; L Zhu; C A Benedict; D Chen; W F Anderson; P M Cannon
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.

Authors:  G D Ritter; G Yamshchikov; S J Cohen; M J Mulligan
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.